Order Article Reprints

Malagnino V, Teti E, Compagno M, Coppola L, Salpini R, Svicher V, Basso M, Battagin G, Panese S, Rossi MC, et al. HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort. Microorganisms. 2021; 9(2):396. https://doi.org/10.3390/microorganisms9020396

Malagnino, Vincenzo, Elisabetta Teti, Mirko Compagno, Luigi Coppola, Romina Salpini, Valentina Svicher, Monica Basso, Giuliana Battagin, Sandro Panese, Maria Cristina Rossi, and et al. 2021. "HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort" Microorganisms 9, no. 2: 396. https://doi.org/10.3390/microorganisms9020396

Malagnino, V., Teti, E., Compagno, M., Coppola, L., Salpini, R., Svicher, V., Basso, M., Battagin, G., Panese, S., Rossi, M. C., Scaggiante, R., Zago, D., Iannetta, M., Parisi, S. G., Andreoni, M., & Sarmati, L. (2021). HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort. Microorganisms, 9(2), 396. https://doi.org/10.3390/microorganisms9020396